Biodesix (BDSX) is at a 52-week high, but can investors hope for more gains in the future? We take a

The consensus price target hints at a 31.9% upside potential for Biodesix (BDSX). While empirical re

Canaccord Genuity analyst Kyle Mikson maintains Biodesix (NASDAQ:BDSX) with a Buy and raises the

HC Wainwright & Co. analyst Yi Chen maintains Biodesix (NASDAQ:BDSX) with a Buy and raises th

Biodesix, Inc. (BDSX) Q2 2026 Earnings Call Transcript

Biodesix NASDAQ: BDSX reported second-quarter 2026 revenue growth of 34% year over year, supported b

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus E

Biodesix (NASDAQ:BDSX) affirms FY2026 sales outlook from $108.000 million-$114.000 million to $108.0

Delivered $26.9 million in revenue, representing 34% growth in Q2 2026; Achieved 82% gross margin in

LOUISVILLE, Colo., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagno

bioAffinity and Biodesix pursue different cancer diagnostics strategies, but which oncology stock of

LOUISVILLE, Colo., July 22, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagno

Shares of Biodesix, Inc. (NASDAQ: BDSX - Get Free Report) have received an average rating of "Modera

Biodesix (BDSX) was a big mover last session on higher-than-average trading volume. The latest trend

Here is how Biodesix, Inc. (BDSX) and BillionToOne (BLLN) have performed compared to their sector so

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's ana

BTSG, BDSX and HQY stand to benefit as digital health, healthcare analytics and nursing care growth

The mean of analysts' price targets for Biodesix (BDSX) points to a 104.3% upside in the stock. Whil

LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnos

Includes real-world clinical data from Biodesix researchers and independent Healthcare Professionals

The mean of analysts' price targets for Biodesix (BDSX) points to a 103.3% upside in the stock. Whil

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus E

Delivered $25.6 million in revenue representing 42% growth in Q1 2026; Achieved 84% gross margin in

LOUISVILLE, Colo., April 20, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagn

Companies Reporting Before The Bell • McEwen Mining (NYSE:MUX) is estimated to report quarterly los

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

Companies Reporting Before The Bell • Passage Bio (NASDAQ:PASG) is estimated to report earnings for